Medical

Breakthrough enzyme therapies open fresh routes for rare metabolic disorders; early findings point to staggering advancements waiting around the corner.

This week's medical highlights: an experimental malaria vaccine with high early efficacy, epigenetic drivers of weight regain, whole-brain RNA imaging, dramatic Lp(a) lowering drugs, an FGFR treatment for achondroplasia, a Crohn’s win, and huge proteomics/genetics advances.

This weekly roundup highlights eight notable medical advances — from single-dose CRISPR reducing hereditary angioedema attacks to newborn genome screening that finds treatable variants — with clinical implications and research next steps.

Breakthrough therapies for septic shock management introduce radical approaches and targeted care strategies. Which treatment will tip the scale next?

Experience breakthrough non-invasive brain stimulation that rebalances moods, reducing depression through innovative protocols, what surprising results lie just beyond the threshold?

A Nature study reports that a personalized mRNA vaccine for pancreatic cancer triggered long‑lived killer T cells and longer relapse‑free survival in responders. Key findings include durable T‑cell persistence and an ongoing randomized trial (IMCODE‑003) to confirm the results.

Explore breakthrough immunotherapy as personalized neoantigen vaccines spark a precision attack on cancer cells; next, unexpected trials expose an anomaly...

Breakthrough point-of-care ultrasound technology transforms emergency care, combining remarkable speed with precision. Suddenly, an unexpected twist emerges, shattering every assumption...

A targeted therapy breakthrough for triple-negative breast cancer sparks hope among researchers as trial data points to a shocking twist.

A new mRNA vaccine wiped out tumors in mice by provoking a virus‑like immune response. Clinical trials are coming; here’s what the science shows and the timeline to watch.